Evidence map›Paper›PMID 42180065›Full record

ArticleFrontiers in oncology2026

Latent class analysis of conventional ultrasound features: a novel approach to predicting non-response to neoadjuvant chemotherapy in breast cancer.

Mei-Lian Zhang, Yi Tang, Cheng-Hua Kong, Li Sun, Xing-Qing Li, Yu Zhou, Zhi-Kui Chen

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mei-Lian Zhang *Department of Ultrasound, Fujian Medical University Union Hospital, Fuzhou, China.
Yi Tang *Department of Ultrasound, Fujian Medical University Union Hospital, Fuzhou, China.
Cheng-Hua KongDepartment of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fujian Medical University, Fuzhou, China.
Li SunDepartment of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fujian Medical University, Fuzhou, China.
Xing-Qing LiDepartment of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fujian Medical University, Fuzhou, China.
Yu ZhouDepartment of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fujian Medical University, Fuzhou, China.
Zhi-Kui ChenDepartment of Ultrasound, Fujian Medical University Union Hospital, Fuzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To determine if holistic patterns derived from conventional ultrasound features are associated with pathological response to neoadjuvant chemotherapy (NAC) in breast cancer, providing a potential basis for non-invasive treatment monitoring. Methods: This study included 509 female breast cancer patients with unilateral primary lesions who underwent NAC followed by surgery. We employed three clustering methodologies to integrate conventional ultrasound features into holistic patterns: the model-based latent class analysis (LCA) and the distance-based K-modes and hierarchical clustering. The association between the resulting patterns and pathological non-response was assessed using Firth logistic regression, with internal validation performed through 10-fold cross-validation and 10, 000 bootstrap resampling. Results: When comparing the three approaches, LCA was identified as the superior classification framework, providing the best balance of statistical model fit, class separation, and meaningful association with clinical outcomes. The optimal LCA model identified two distinct sonographic patterns, referred to as Pattern A and Pattern B. Pattern B was significantly associated with a 2.51-fold higher (95% CI: 1.05-5.99) likelihood of pathological non-response compared to Pattern A. In subgroup analyses, among defined high-risk groups, Pattern B was linked to an increased risk of pathological non-response ranging from 12.84% (95% CI: 5.74%-23.59%) to 21.34% (95% CI: 13.63%-28.32%), whereas in non-high-risk groups the corresponding increase ranged from 1.12% (95% CI: 0.79%-1.51%) to 3.45% (95% CI: 2.60%-4.47%). Conclusion: Patterns of conventional ultrasound features derived through LCA may offer a preliminary indication for identifying breast cancer patients less likely to benefit from NAC, potentially informing more individualized treatment planning following external validation.

Indexed as

breast cancerindividualized treatmentneoadjuvant chemotherapypathological responseultrasound image features

Identifiers

PMID42180065
PMCPMC13189786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.